About Brainreader
Brainreader is a Danish healthcare AI company that specializes in quantitative brain MRI analysis through its flagship software, Neuroreader®. Founded in 2011, the company develops FDA-cleared and CE-marked medical device software that provides clinicians with objective, reproducible brain volumetric data. Neuroreader® automates the analysis of 3D T1-weighted MRI scans, quantifying over 65 to 83 specific brain structures, including the hippocampus, cortical lobes, and ventricles, in under 10 minutes. This rapid analysis helps physicians in the early detection, diagnosis, and monitoring of neurodegenerative diseases by identifying subtle atrophy patterns that may be invisible to the human eye.
For physicians, Neuroreader® serves as a clinical decision-support tool, offering objective data in the form of volumes (mL), percentiles, and Z-scores, and enabling longitudinal tracking of brain volume changes over time. This quantitative insight is crucial for conditions such as Alzheimer’s disease and dementia, mild cognitive impairment (MCI), traumatic brain injury (TBI), and epilepsy. The software integrates seamlessly into existing PACS or can be used via web upload, streamlining workflow without requiring extensive staff retraining or additional patient time. By providing accurate and actionable insights, Brainreader aims to empower healthcare professionals to make more informed clinical decisions, design effective treatment plans, and ultimately improve patient outcomes.
Focus Areas
Business Intelligence
| Technology | Cloud-based platform, AI-powered deep learning algorithms, integrates with PACS, processes DICOM images from MRI scans |
What Physicians Need to Know
For physicians, Brainreader's Neuroreaderu00ae offers a powerful tool for earlier and more confident diagnosis and monitoring of neurodegenerative diseases, TBI, and epilepsy. The automated, quantitative reports, delivered in under 10 minutes, can significantly reduce the time to diagnosis and free up valuable physician time. The objective data and longitudinal tracking capabilities allow for better differentiation between conditions with overlapping symptoms, more informed treatment planning, and clearer communication with patients and their families about disease progression. Integrating Neuroreaderu00ae into existing MRI workflows is designed to be seamless, whether through web-based access, a mediation server, or direct PACS integration.
Brainreader's Neuroreaderu00ae is designed for seamless integration into existing clinical workflows. It supports PACS integration for automated image routing and report delivery, and also offers secure web portal access and mediation server options. This flexibility allows for easy deployment across various clinical and enterprise environments, including single-site clinics and large health systems.
What the Web Says
Brainreader is a Danish medical device company that has developed Neuroreader, an AI-enabled software designed to analyze MRI scans of the brain to detect subtle changes in brain volume. This technology aims to assist in the early diagnosis and monitoring of neurodegenerative diseases like Alzheimer's, epilepsy, and depression, as well as traumatic brain injuries. The software provides quantitative, reproducible measurements of brain structures, offering a more objective assessment than visual interpretation alone.
Overall: PositiveStrengths
- Provides objective, reproducible brain volume measurements.
- Aids in earlier detection of neurodegenerative diseases and traumatic brain injuries.
- Analyzes 45-83 specific brain structures.
- Delivers automated reports in less than five minutes.
- Integrates seamlessly into existing clinical workflows.
- FDA-cleared and supported by peer-reviewed research.
Limitations
- Some general concerns exist regarding the evidence gap for automated MRI analysis in dementia.
- AI tools for MRI analysis are still in development and may have a high margin of error, especially in distinguishing normal anatomical differences from lesions.
- AI diagnostic aids can be expensive, potentially increasing overall healthcare costs.
- Some AI interview platforms, which may share similar underlying AI technology, are criticized for being less personal and lacking in interactive questioning or data storage for later comparisons.
- The accuracy of AI models in real-world data may differ from testing model accuracy.
Based on reviews from: AuntMinnie, Brainreader Official Website, Reddit, PitchBook
Last updated: 2026-09-21
Videos
News, demos, and interviews about Brainreader.
Videos load interactively. If none appear, search YouTube for Brainreader →
Press & Coverage
Frequently Asked Questions
Comparisons
Related Companies
Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]
Veeva Systems is a global leader in cloud-based software solutions specifically designed for the life sciences industry, including pharmaceutical and biotech companies. The company’s offerings are crucial for managing various aspects of drug development, pharmaceutical manufacturing, and commercial operations. Their platforms help clients navigate complex regulatory requirements, improve operational efficiency, and accelerate the delivery of […]
The University at Buffalo (UB) is a prominent public research university and a flagship institution of the State University of New York (SUNY) system. While UB itself is a broad academic institution, the provided URL (halsted.compbio.buffalo.edu) points to a specific area within UB focused on computational biology. This division is actively engaged in healthcare AI […]
SOPHiA GENETICS is a healthcare AI company that has developed a cloud-native, AI-driven SaaS platform called SOPHiA DDM™. This platform is designed to enable hospitals, clinical laboratories, academic medical centers, and biopharmaceutical companies to analyze and interpret complex genomic, radiomic, and multimodal healthcare data. The company’s mission is to democratize data-driven medicine, providing actionable insights […]
Prenaital is an AI-driven healthcare company focused on revolutionizing maternal care by improving the early detection and management of high-risk pregnancies. Their AI models analyze ultrasound images to identify at-risk pregnancies, including those with abnormal fetal growth and a risk of preterm birth, with significantly higher accuracy than current clinical practices—detecting 25-50% more high-risk cases. […]
PHQ Screeners is a free, open-access resource maintained by Pfizer, providing a comprehensive suite of Patient Health Questionnaire (PHQ) and Generalized Anxiety Disorder (GAD-7) screening instruments. These tools were developed by Drs. Robert L. Spitzer, Janet B.W. Williams, and Kurt Kroenke with an educational grant from Pfizer, and are widely utilized in primary care and […]